Greater access to life-changing medicine for Australians with ADHD

Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).   Federal Member for Page Kevin Hogan said from today the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are…

Big things to come in 2021

Australia is leading the world in fighting COVID-19 and our economy is one of the strongest globally. Speaking to many of our local businesses, they are starting to bounce back.   A recent Deloitte Access Economics report says, “you’d rather be here (Australia) than almost anywhere else” in the world. It continues by saying our…